Copy of Brain Fog Statistics 2026
SureokGo Brain Fog Database Marker Alpha-7X9
Brain Fog: 175 Years of a Silent Epidemic
From Victorian "brain fag" to modern $5 trillion crisis. 100+ statistics. Complete history. Why it's still not a diagnosis. Every condition. The mechanisms. What actually works.
Overview: The Crisis Nobody Saw Coming
In October 2025, researchers from Yale School of Medicine published findings in Neurology that confirmed what millions had been experiencing: cognitive disability in America had risen dramatically—and the trend began years before anyone had heard of COVID-19. For a deeper look at What is brain fog? see our research overview.
"The trajectory suggests this increase began around 2016, preceding the COVID-19 pandemic."
— Adam de Havenon, MD, Yale School of MedicineThe inflection point was 2016—four years before SARS-CoV-2 emerged. While Long COVID has accelerated cognitive decline, it didn't create the crisis. Something else did: a convergence of ultra-processed diets, chronic stress, social isolation, screen saturation, and metabolic dysfunction.
Sample Note on 28.2% Statistic
This study surveyed users of a cognitive health app (Mindset Technologies). The sample was 89% female and self-selected — it may overestimate brain fog prevalence in the general population. The figure reflects self-reported brain fog among respondents, not a clinically diagnosed rate.
| Demographic | 2013 Rate | 2023 Rate | Change | Source |
|---|---|---|---|---|
| Overall U.S. adults | 5.3% | 7.4% | +40% | [6] |
| Adults under 40 | 5.1% | 9.7% | +90% | [7] |
| Income under $35K | 8.8% | 12.6% | +43% | [8] |
| Income over $75K | 1.8% | 3.9% | +117% | [9] |
| No high school diploma | 11.1% | 14.3% | +29% | [10] |
| College degree | 2.1% | 3.6% | +71% | [11] |
Sources [6-11]: Yale School of Medicine/Neurology, 2025
A Brief History of "Brain Fog"
Brain fog is not a new phenomenon. The experience of mental exhaustion, clouded thinking, and cognitive difficulty has been documented across cultures for millennia. What has changed is how we name it, who we attribute it to, and whether we take it seriously.
Historical Synonyms for Brain Fog
Throughout history, the same experience has been called: brain fag, neurasthenia, nervous exhaustion, mental fog, clouding of consciousness, fibro fog, chemo brain, and cognitive dysfunction. The terminology changes; the suffering doesn't.
Historical Treatments: From Rest Cure to Brain Tonics
If brain fog is not a new phenomenon, neither are attempts to treat it. Victorian physicians developed elaborate therapies for neurasthenia and "brain fag"—some harmful, some prescient, and some that foreshadowed modern nootropics.
The Rest Cure (1873-1925)
The dominant treatment for mental exhaustion in the late 19th century was the "rest cure," developed by Philadelphia neurologist Silas Weir Mitchell. Originally designed for Civil War veterans with "nervous injuries," Mitchell adapted it for what he called "nervous women, who, as a rule, are thin, and lack blood."
The Rest Cure Protocol
- Complete bed rest: 6-8 weeks, often longer
- Isolation: No visitors, no reading, no writing, no intellectual stimulation
- Force-feeding: Up to 2 quarts of milk daily, sometimes 18+ raw eggs
- Electrotherapy: Mild electrical stimulation to prevent muscle atrophy
- Massage: To maintain circulation during immobility
The cure was controversial even then. Charlotte Perkins Gilman's 1892 story "The Yellow Wallpaper" depicted a woman driven to madness by rest cure confinement. Virginia Woolf also underwent and criticized the treatment. A 1998 BMJ paper called for "putting the rest cure to rest—again," noting that enforced inactivity worsens, rather than improves, fatigue syndromes. [27] Wessely, BMJ, 1998
"Brain work having ceased, mental expenditure is reduced to a slight play of emotions and an easy drifting of thought."
— S. Weir Mitchell, "Fat and Blood" (1877) [28]Brain Tonics and Patent Medicines
For those who couldn't afford the rest cure, the late Victorian era offered an alternative: "brain tonics." These patent medicines promised to restore mental energy and cure neurasthenia through pharmacological means.
Vin Mariani (1863)
The most famous brain tonic was Vin Mariani, a coca wine developed by French chemist Angelo Mariani. Combining Bordeaux wine with coca leaf extract (containing approximately 6-7mg cocaine per ounce), it was endorsed by Pope Leo XIII, Queen Victoria, Thomas Edison, and over 8,000 physicians. [31] Mariani Album, historical records
Pemberton's "Brain Tonic" (1886)
Pharmacist John Pemberton developed "French Wine Coca" as a treatment for "neurasthenia, nervous afflictions, and all nervous troubles." When Atlanta enacted prohibition laws, he reformulated it without alcohol—creating Coca-Cola, initially marketed as "a valuable Brain Tonic, and a cure for all nervous affections." [32] Coca-Cola Company archives
Ingredients That Persisted
Not all Victorian remedies were quackery. Several ingredients from 19th-century tonics appear in modern nootropic formulations:
| Victorian Ingredient | Modern Form | Current Evidence | Source |
|---|---|---|---|
| Kola nut / caffeine | Caffeine supplements | Well-established cognitive enhancer in moderate doses | [33] |
| Valerian root | Valerian extracts | Used for anxiety and sleep; modest evidence | [34] |
| Iron supplements | Iron + B-vitamins | Effective when deficiency is present | [35] |
| Beef/blood tonics | B12, iron, protein | Components now understood individually | [36] |
| Phosphorus compounds | Phosphatidylserine | Moderate evidence for cognitive support | [37] |
Sources [33-37]: Various pharmacological reviews
Why Brain Fog Isn't a Clinical Diagnosis (Yet)
Despite affecting a large share of adults, "brain fog" has no dedicated diagnostic code in any major classification system. This matters: without a code, there's no standardized tracking, limited insurance coverage, and fragmented research funding.
Current Classification Status
| System | Status | What's Used Instead | Source |
|---|---|---|---|
| ICD-10 | No specific code | R41.89 "Other symptoms and signs involving cognitive functions and awareness" | [38] |
| ICD-11 | Partial recognition | MB20.2 "Clouding of consciousness" — includes "brain fog" as inclusion term | [39] |
| DSM-5-TR | Not recognized | "Cognitive disorder not otherwise specified" or symptom of other conditions | [40] |
[38] WHO ICD-10; [39] WHO ICD-11; [40] APA DSM-5-TR
Why No Diagnosis? Three Barriers
1. Definition Problem
Researchers can't agree what brain fog is. A 2025 review in Trends in Neurosciences identified three competing definitions: (a) a single symptom, (b) a syndrome (bounded set of symptoms), or (c) an inherently ambiguous umbrella term. Without consensus, standardization is impossible. [41] Ross et al., Trends in Neurosciences, 2025
2. No Biomarker
Until 2024, there was no objective test for brain fog. The Trinity College Dublin study showing blood-brain barrier disruption on MRI may change this—but the imaging isn't yet standardized or widely available. [42] Greene et al., Nature Neuroscience, 2024
3. Symptom Overlap
Brain fog symptoms overlap substantially with depression, anxiety, fatigue, and sleep disorders. Clinicians often attribute cognitive complaints to these conditions rather than recognizing brain fog as distinct. [43] Trends in Neurosciences, 2025
"There's this idea in medicine that if we can't break a symptom down into a latinized medical term then we've failed. Instead, it just might be a reason to keep investigating."
— Colin Doherty, MD, Trinity College Dublin, National Geographic 2025 [44]Every Condition Associated with Brain Fog
Brain fog isn't unique to Long COVID. It appears in over 20 conditions—some with prevalence rates exceeding 90%. This section catalogs every condition with documented brain fog as a symptom.
| Condition | Brain Fog Prevalence | Common Name | Source |
|---|---|---|---|
| POTS (Postural Orthostatic Tachycardia Syndrome) | 96% | — | [45] |
| ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) | 85-89% | — | [46] |
| Long COVID (U.S., non-hospitalized) | 86% | COVID brain fog | [47] |
| Central Narcolepsy/Primary Hypersomnia | 74-86% | — | [48] |
| Fibromyalgia | 70-80% | Fibro fog | [49] |
| Perimenopause | 68% | Menopause brain fog | [50] |
| Traumatic Brain Injury | 65% | — | [51] |
| Chemotherapy | 44-75% | Chemo brain, chemo fog | [52] |
| Lupus (SLE) | 30-40% | Lupus fog | [53] |
| Multiple Sclerosis | 40-65% | MS cognitive fog | [54] |
| Parkinson's Disease | 20-50% | — | [55] |
| Depression | 85-94% | — | [56] |
| Anxiety Disorders | Common | — | [57] |
| PTSD | Common | — | [58] |
| ADHD | Common | — | [59] |
| Hypothyroidism | Common | Thyroid brain fog | [60] |
| Hashimoto's Thyroiditis | Common | — | [61] |
| Diabetes (Type 2) | Common | — | [62] |
| Ehlers-Danlos Syndrome | Common | — | [63] |
| Celiac Disease | Common | Gluten fog | [64] |
| Inflammatory Bowel Disease | >50% | — | [65] |
| Chronic Pain Conditions | 15-40% | — | [66] |
| Lyme Disease | Common | Lyme brain | [67] |
| Mold Exposure (CIRS) | Common | — | [68] |
| Sleep Apnea | Common | — | [69] |
| Pregnancy | 50-80% | Pregnancy brain, mom brain | [70] |
| Anemia (Iron Deficiency) | Common | — | [71] |
Sources: [45-46, 48] Trends in Neurosciences 2025; [47] Northwestern/Frontiers in Human Neuroscience 2026; [49] Duke Health; [50] Climacteric 2022; [51-52] Trends in Neurosciences 2025; [53] Duke Health; [54] National MS Society; [55] National Parkinson Foundation; [56] DSM-5; [57-59] Multiple studies; [60] Cleveland Clinic; [61-64] Multiple studies; [65] GI Study 2024; [66] Trends in Neurosciences 2025; [67-71] Multiple sources
The Common Thread
What connects these disparate conditions? Emerging research points to neuroinflammation, blood-brain barrier dysfunction, and immune dysregulation as shared mechanisms. Brain fog may be a final common pathway for many different insults to the brain.
The Biology: What's Actually Happening in the Brain
For decades, brain fog was dismissed as psychological. Recent research has identified concrete biological mechanisms—providing validation for millions of patients and opening pathways for treatment.
1. Blood-Brain Barrier Disruption Confirmed 2024
The blood-brain barrier (BBB) is a highly selective membrane that protects the brain from toxins, pathogens, and inflammatory molecules. A landmark 2024 study in Nature Neuroscience found that Long COVID patients with brain fog have significantly "leaky" blood-brain barriers.
"For the first time, we have been able to show that leaky blood vessels in the human brain, in tandem with a hyperactive immune system may be the key drivers of brain fog."
— Matthew Campbell, PhD, Trinity College Dublin [74]2. Neuroinflammation
When the immune system detects a threat, it produces inflammatory cytokines. In healthy people, this response resolves. In brain fog, inflammation persists—activating microglia (the brain's immune cells) and damaging neural tissue.
3. Coagulation Abnormalities
Brain fog patients show dysregulated clotting systems. Microclots may impair blood flow to the brain, reducing oxygen and nutrient delivery to neurons. [77] Pretorius et al., Cardiovascular Diabetology, 2021
4. Autoantibodies
Some patients produce autoantibodies that attack healthy brain tissue. This may explain why brain fog persists long after the initial trigger resolves. [78] Wallukat et al., Journal of Translational Medicine, 2021
5. Gut-Brain Axis Disruption
The gut microbiome communicates with the brain via the vagus nerve. Disruption of this axis—common after infection, antibiotic use, or dietary changes—may contribute to cognitive symptoms. [79] Cryan et al., Physiological Reviews, 2019
6. Mitochondrial Dysfunction
Mitochondria produce cellular energy. When they malfunction, neurons can't fire efficiently—leading to the subjective experience of mental sluggishness and excessive cognitive effort. [80] Picard et al., Nature Reviews Neuroscience, 2022
Economic Impact: The $5 Trillion Crisis
At the 2025 World Economic Forum in Davos, brain health emerged as a G7 priority for the first time. The reason: McKinsey Health Institute's estimate that brain health disorders now impose a staggering $5 trillion annual burden on the global economy.
Note on McKinsey Projections
McKinsey's 2030 projections have varied across publications ($6T, $15T, $16T). The $16 trillion figure reflects their most recent estimate. All projections depend on methodology and which conditions are included under "brain health."
International Comparisons: Brain Fog Across Borders
Brain fog is not just an American phenomenon—but how it's reported, recognized, and studied varies dramatically by country. Cultural factors, healthcare access, and stigma all shape how cognitive symptoms are acknowledged.
Note on International Data
International statistics should be interpreted with caution. Reporting rates reflect healthcare access, cultural attitudes toward cognitive symptoms, and diagnostic practices—not necessarily true underlying prevalence.
Long COVID Brain Fog by Country
Brain Fog Prevalence in Long COVID Patients (Non-Hospitalized)
Source: [87] Northwestern Medicine / Frontiers in Human Neuroscience, 2026
Correction Note
A previous version of this page cited "8–26% of UK adults reported impaired concentration in the REACT cohort" and attributed it to NEJM 2024. The Hampshire et al. study measured cognitive deficits via online tasks in the UK Biobank, not self-reported concentration in the REACT cohort. This stat has been removed pending identification of the correct source.
Root Causes: What's Driving the Crisis
The data points to a convergence of modern lifestyle factors—not a single pathogen or event. These factors overlap and compound each other.
Ultra-Processed Food
Financial Stress
Loneliness
Sleep Deprivation
Screen Time
Gender, Hormones, and Brain Fog
Brain fog affects women more than men—and hormonal factors play a significant role.
Perimenopause and Menopause
The transition to menopause involves dramatic changes in estrogen and progesterone—hormones that affect brain function. Many women experience their first significant cognitive symptoms during this period. Research suggests these symptoms often improve after menopause is complete—the transition period itself may be the most difficult.
Children and Teenagers: The Developing Brain at Risk
Brain fog is not just an adult phenomenon. Children and adolescents experience cognitive difficulties from multiple sources—and the developing brain may be particularly vulnerable.
Long COVID in Children
Screen Time and the Adolescent Brain
Sleep Deprivation in Adolescence
Long COVID: The Accelerant
Long COVID has brought unprecedented attention to brain fog—but it didn't create the phenomenon. The inflection point for cognitive decline was 2016. Long COVID has accelerated an existing trend.
Context for 86% Statistic
The 86% figure is from the U.S. cohort of a cross-continental comparison study of non-hospitalized patients. Rates varied significantly by country (63% Nigeria, 62% Colombia, 15% India), suggesting cultural and healthcare access factors influence reporting. The 20–65% range below reflects broader estimates across different study methodologies.
Cognitive Impact by COVID Severity
| Severity | IQ Equivalent Drop | Recovery Timeline | Source |
|---|---|---|---|
| Mild COVID (resolved 4-12 weeks) | −3 points | Usually resolves within months | [116] |
| Long COVID (symptoms 12+ weeks) | −6 points | Months to years; variable | [117] |
| ICU admission | −9 points | May persist 42+ months | [118] |
Sources [116-118]: Hampshire et al., NEJM, 2024. Note: A previously listed "Hospitalized (not ICU): −7 points" category has been removed as it was not a separate breakdown in the original study.
What Brain Fog Actually Feels Like
Statistics capture the scale; phenomenology captures the texture. A 2023 study analyzed 717 first-person descriptions of brain fog from Reddit to understand what brain fog feels like to those experiencing it.
| Experience | % of Descriptions | What It Means | Source |
|---|---|---|---|
| Forgetfulness | 36% | Memory lapses, losing track of tasks | [119] |
| Difficulty concentrating | 30% | Unable to focus, easily distracted | [120] |
| Dissociation | 24% | Feeling "unreal," detached from self | [121] |
| Cognitive slowness | 18% | Thoughts feel effortful, delayed | [122] |
| Word-finding difficulties | 16% | Can't retrieve familiar words | [123] |
| "Fuzziness" or pressure | 7% | Physical sensation of cloudiness | [124] |
| Mental fatigue | 6% | Exhaustion from thinking | [125] |
Sources [119-125]: Reddit phenomenology study, 2023
"It feels like there's a bouncer in my head blocking my thoughts as I try to think and do things."
— Study participant, YoungMinds [126]"Someone pulled the emergency brake in my brain while the world keeps moving around me."
— Study participant, Reddit analysis [127]What Actually Works: Evidence-Based Interventions
Despite the scale of the crisis, evidence-based interventions exist. The strongest evidence supports lifestyle modifications — exercise, sleep, diet, and stress management — while targeted supplementation and clinical interventions show promising results for specific populations. Recommended reading - 54 ways to get rid of brain fog
Exercise Strong Evidence
What the research recommends
150 minutes/week of moderate aerobic exercise (brisk walking, cycling, swimming) is the most consistently supported intervention for cognitive function. Exercise increases BDNF (brain-derived neurotrophic factor), promotes neurogenesis in the hippocampus, reduces neuroinflammation, and improves cerebrovascular health. Even a single 20-minute walk improves attention and working memory for several hours afterward.
Sleep Strong Evidence
Why sleep is non-negotiable for brain fog
During deep sleep (N3/slow-wave), the glymphatic system clears metabolic waste — including amyloid-beta — from the brain. REM sleep consolidates memories and supports emotional processing. Chronic sleep restriction (even 1.5 hours less than optimal) produces cumulative cognitive deficits equivalent to total sleep deprivation. Consistent sleep/wake times matter as much as total hours: irregular schedules disrupt circadian regulation of cortisol, which directly impairs prefrontal cortex function.
Diet Strong Evidence
Diet specifics that matter
Ultra-processed food consumption is independently associated with faster cognitive decline — a 10% increase in UPF intake correlates with measurably poorer executive function and memory scores. The MIND diet (a hybrid of Mediterranean and DASH) specifically targets brain health: leafy greens (6+ servings/week), berries (2+/week), nuts (5+/week), fatty fish (1+/week), and olive oil as the primary cooking fat. The mechanism involves reducing neuroinflammation, supporting blood-brain barrier integrity, and providing precursors for neurotransmitter synthesis.
Stress Management & Mindfulness Strong Evidence
How chronic stress drives brain fog
Chronic stress elevates cortisol, which directly impairs hippocampal function and prefrontal cortex activity — the exact brain regions responsible for memory encoding and executive function. Mindfulness-based stress reduction (MBSR) programs increase cortical thickness in attention-regulating brain regions and reduce amygdala reactivity. Even brief daily practices (10–15 minutes) show measurable improvements in sustained attention and working memory accuracy. Cognitive behavioral therapy for insomnia (CBT-I) is also strongly supported for stress-related cognitive symptoms.
Hydration Moderate Evidence
Mild dehydration impairs short-term memory, attention, and psychomotor function before thirst is perceived. The brain is approximately 75% water; even modest fluid deficits reduce cerebral blood flow and increase fatigue. While individual needs vary, 2–3 liters/day of total fluid intake is a reasonable baseline for most adults — more in hot climates or with exercise.
Social Connection Moderate Evidence
The 2024 Lancet Commission added social isolation as one of 14 modifiable risk factors for cognitive decline. Meaningful social engagement stimulates complex cognitive processing — conversation requires attention, memory retrieval, emotional regulation, and language production simultaneously. Loneliness increases systemic inflammation (elevated IL-6, CRP), which crosses the blood-brain barrier and contributes to neuroinflammation — one of the core mechanisms of brain fog.
Supplements With Evidence
| Supplement | Evidence | Key Finding | Dose | Source |
|---|---|---|---|---|
| Omega-3 (DHA/EPA) | Strong | Improved memory, processing speed in multiple RCTs | 1000–2000mg/day | [132] |
| B-Complex | Strong | 84% improvement in B12-deficient patients | Methylated forms | [133] |
| Phosphatidylserine | Moderate | 2024 RCT: improved short-term memory | 300mg/day | [134] |
| Magnesium | Moderate | Higher intake → larger brain volumes | 300–400mg/day | [135] |
| Creatine | Moderate | Improved memory under stress/sleep deprivation | 3–5g/day | [136] |
| Huperzine A | Moderate | Meta-analysis of 20 RCTs: improved MMSE scores | 200–400mcg/day | [137] |
| Lion's Mane | Emerging | Small trials positive; NGF mechanism | 500-3000mg/day | [138] |
Sources [132-138]: Various RCTs and meta-analyses. Supplements are not a substitute for lifestyle interventions. Consult a healthcare provider before starting any supplement regimen.
Disclosure: This database is published by SureOKGo. Our supplement FOG OFF contains Phosphatidylserine (200mg) and Huperzine A (60mcg) — both listed above — alongside Black Maca Root, L-Glutamic Acid, 5-HTP, Alpha Lipoic Acid, and Benfotiamine. Formulated by Dr. Alexandru-Theodor Amarfei, M.D. No statistic on this page promotes our products.
Clinical Interventions Emerging
For individuals with persistent brain fog that doesn't respond to lifestyle changes, several clinical approaches are under investigation or in early use:
| Intervention | Target Mechanism | Status |
|---|---|---|
| Cognitive Behavioral Therapy (CBT) | Maladaptive thought patterns, sleep, stress | Established — effective for stress-related cognitive symptoms |
| Cognitive Rehabilitation | Compensatory strategies for attention/memory | Established in TBI/stroke — adapting for Long COVID |
| Low-Dose Naltrexone (LDN) | Neuroinflammation, microglial modulation | Phase 2 trials for Long COVID |
| Hyperbaric Oxygen Therapy | Cerebral blood flow, tissue oxygenation | Small RCTs showing improvement; larger trials ongoing |
| Transcranial Direct Current Stimulation | Prefrontal cortex activation | Promising pilot data; not yet standardized |
The Hierarchy of Interventions
Start here → Sleep optimization + daily movement + anti-inflammatory diet form the foundation. These three alone resolve a significant proportion of brain fog cases. Then add → Stress management practices and social engagement. Consider → Targeted supplementation for specific deficiencies (B12, iron, vitamin D, omega-3). If persistent → Medical evaluation to rule out thyroid, autoimmune, or other underlying conditions. Cognitive rehabilitation and clinical interventions for refractory cases.
The Future: What's Coming for Brain Fog
For 175 years, brain fog has existed in a diagnostic limbo—real to those who experience it, but invisible to the medical establishment. That's changing.
Research Funding
Clinical Trials to Watch
| Treatment | Mechanism | Trial Status | Source |
|---|---|---|---|
| Bezisterim | Anti-inflammatory; targets neuroinflammation | Phase 2 trials | [141] |
| Low-Dose Naltrexone (LDN) | Immune modulation; reduces microglial activation | Phase 2 trials | [142] |
| Hyperbaric Oxygen Therapy | Increases brain oxygenation; may repair BBB | Small trials positive | [143] |
| Photobiomodulation | Near-infrared light; mitochondrial function | Early trials | [144] |
| Tocilizumab | IL-6 inhibitor; reduces systemic inflammation | Being studied for Long COVID | [145] |
Sources [141-145]: ClinicalTrials.gov and research publications
Measuring Brain Fog: The Brain Fog Scale
One reason brain fog has been difficult to study is the lack of standardized measurement. That changed in 2024 with the validation of the Brain Fog Scale (BFS)—the first dedicated self-report instrument.
The Brain Fog Scale (BFS)
Developed by Debowska et al. (2024) and validated in both Polish and English populations, the BFS is a 23-item self-report measure with three subscales:
| Subscale | Items | What It Measures | Source |
|---|---|---|---|
| Mental Fatigue | 6 items | Cognitive exhaustion, mental tiredness | [146] |
| Impaired Cognitive Acuity | 9 items | Sharpness, clarity, processing speed | [147] |
| Confusion | 8 items | Disorientation, difficulty following threads | [148] |
Sources [146-148]: Debowska et al., 2024
Complete Source Index
Every statistic in this database is individually cited. Below is the full reference list with direct links to primary sources. Citations marked 📄 link to the original study or official page.
Section 1: Overview — The Crisis in Numbers
| # | Citation |
|---|---|
| [1] | de Havenon A, et al. "Trends in Cognitive Disability in the United States, 2013–2023." Neurology, 2025. 📄 doi:10.1212/WNL.0000000000214226 |
| [2–11] | de Havenon A, et al. Neurology, 2025. Subgroup analyses: under-40, income, education, overall U.S. adult rates. 📄 Same source as [1] |
| [3] | Drapała J, et al. "Brain Fog: Prevalence and Associated Factors." Frontiers in Human Neuroscience, 2024 (n=25,796). 📄 Full text |
Section 2: History — From "Brain Fag" to Brain Fog
| # | Citation |
|---|---|
| [12] | Ayonrinde OA. "'Brain Fag': A Syndrome Associated with 'Overstudy' and Mental Exhaustion in 19th Century Britain." International Review of Psychiatry, 2020. 📄 doi:10.1080/09540261.2020.1775428 |
| [13] | Dunglison R. A Dictionary of Medical Science, 1851. Entry for "brain-fag." Historical text — no digital link available. |
| [14] | Beard GM. "Neurasthenia, or Nervous Exhaustion." Boston Medical and Surgical Journal, 1869; 80: 217–221. Historical text — referenced in 📄 Goetz, Neurology, 2001 |
| [15–16] | Ayonrinde OA. International Review of Psychiatry, 2020. Class distinctions and British Newspaper Archive analysis (83,479 references). 📄 Same source as [12] |
| [17] | Mitchell SW. Fat and Blood: An Essay on the Treatment of Certain Forms of Neurasthenia and Hysteria, 1877. Historical text — available via 📄 Internet Archive |
| [18] | Prince R. "The 'Brain Fag' Syndrome in Nigerian Students." Journal of Mental Science, 1960; 106: 559–570. 📄 PubMed |
| [19] | American Psychiatric Association. DSM-III, 1980. Reference standard — available via APA Publishing. |
| [20] | Multiple sources on fibro fog, chemo brain, and ME/CFS cognitive dysfunction in the 1990s. |
| [21] | Taquet M, et al. "6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19." The Lancet Psychiatry, 2021. 📄 Full text |
| [22] | World Health Organization. ICD-10-CM code U09.9, "Post COVID-19 condition," 2021. 📄 WHO ICD-10 |
| [23] | Debowska A, et al. "Brain Fog Scale (BFS): Scale Development and Validation." Personality and Individual Differences, 2024; 216: 112427. 📄 ScienceDirect |
| [24] | Greene C, et al. "Blood-brain barrier disruption in Long COVID-associated cognitive impairment." Nature Neuroscience, 2024. 📄 Full text |
| [25] | de Havenon A, et al. Neurology, 2025. 📄 Same source as [1] |
| [26] | Denno P, Zhao S, Husain M, Hampshire A. "Defining Brain Fog Across Medical Conditions." Trends in Neurosciences, 2025; 48(5). 📄 Full text (open access) |
Section 3: Historical Treatments
| # | Citation |
|---|---|
| [27] | Wessely S. "Old Wine in New Bottles: Neurasthenia and 'ME'." Psychological Medicine, 1990. 📄 Cambridge Core |
| [28] | Mitchell SW. Fat and Blood, 1877. Direct quotation. 📄 Internet Archive |
| [29–30] | Historical industry estimates: U.S. patent medicine market and product counts, circa 1900. Period sources — no digital link. |
| [31] | Mariani Album and historical records: Vin Mariani endorsements and composition. Period sources. |
| [32] | Coca-Cola Company archives: Pemberton's original "Brain Tonic" marketing. Historical records. |
| [33–37] | Various pharmacological reviews on caffeine, valerian, iron, B12/protein, and phosphatidylserine. Multiple journal sources. |
Section 4: Clinical Status — Still Not a Diagnosis
| # | Citation |
|---|---|
| [38] | World Health Organization. ICD-10: Code R41.89, "Other symptoms and signs involving cognitive functions and awareness." 📄 WHO ICD-10 Browser |
| [39] | World Health Organization. ICD-11: Code MB20.2, "Clouding of consciousness." 📄 WHO ICD-11 Browser |
| [40] | American Psychiatric Association. DSM-5-TR. Brain fog not recognized as standalone diagnosis. Reference standard. |
| [41–43] | Denno P, et al. "Defining Brain Fog Across Medical Conditions." Trends in Neurosciences, 2025. Three competing definitions, symptom overlap analysis. 📄 Same source as [26] |
| [42] | Greene C, et al. Nature Neuroscience, 2024. 📄 Same source as [24] |
| [44] | Doherty C, quoted in "What Is Brain Fog?" National Geographic, 2025. 📄 Article |
Section 5: All Conditions Where Brain Fog Appears
| # | Citation |
|---|---|
| [45–46] | Denno P, et al. Trends in Neurosciences, 2025. POTS (96%) and ME/CFS (85–89%). 📄 Same source as [26] |
| [47] | Graham EL, et al. "Long COVID Brain Fog Far More Common in US Than India, Other Nations." Northwestern Medicine / Frontiers in Human Neuroscience, 2026. 📄 Press release |
| [48] | Denno P, et al. Trends in Neurosciences, 2025. Narcolepsy/hypersomnia (74–86%). 📄 Same source as [26] |
| [49] | Duke Health. "Fibromyalgia and Cognitive Dysfunction" (70–80%). 📄 Duke Health |
| [50] | Gava G, et al. "Cognition, Mood and Sleep in Menopausal Transition." Climacteric, 2022. 📄 PubMed |
| [51–52] | Denno P, et al. Trends in Neurosciences, 2025. TBI (65%) and chemotherapy (44–75%). 📄 Same source as [26] |
| [53] | Duke Health. "Lupus/SLE Cognitive Dysfunction" (30–40%). 📄 Duke Health |
| [54] | National Multiple Sclerosis Society. "MS Cognitive Fog" (40–65%). 📄 NMSS |
| [55] | National Parkinson Foundation. "Parkinson's Cognitive Dysfunction" (20–50%). 📄 Parkinson.org |
| [56] | American Psychiatric Association. DSM-5. Depression and cognitive symptoms (85–94%). Reference standard. |
| [57–59] | Multiple studies on anxiety, PTSD, and ADHD cognitive dysfunction. |
| [60] | Cleveland Clinic. "Hypothyroidism and Brain Fog." 📄 Cleveland Clinic |
| [61–64] | Multiple studies on Hashimoto's, diabetes, EDS, and celiac disease cognitive symptoms. |
| [65] | GI Study, 2024. Inflammatory bowel disease and cognitive dysfunction (>50%). |
| [66] | Denno P, et al. Trends in Neurosciences, 2025. Chronic pain conditions (15–40%). 📄 Same source as [26] |
| [67–71] | Multiple sources on Lyme disease, mold/CIRS, sleep apnea, pregnancy brain, and anemia cognitive symptoms. |
Section 6: Mechanisms — What's Actually Happening in the Brain
| # | Citation |
|---|---|
| [72–74] | Greene C, et al. "Blood-brain barrier disruption and neuroinflammation in Long COVID." Nature Neuroscience, 2024. Includes Campbell M quote. 📄 Full text |
| [75–76] | "Microglial dysfunction and inflammatory cytokines in COVID-19." Nature Neuroscience, 2025. 📄 Full text |
| [77] | Pretorius E, et al. "Persistent clotting protein pathology in Long COVID/PASC." Cardiovascular Diabetology, 2021; 20: 172. 📄 Full text (open access) |
| [78] | Wallukat G, et al. "Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms." Journal of Translational Autoimmunity, 2021; 4: 100100. 📄 PubMed · 📄 PMC full text |
| [79] | Cryan JF, et al. "The Microbiota-Gut-Brain Axis." Physiological Reviews, 2019; 99(4): 1877–2013. 📄 PubMed |
| [80] | Picard M, et al. "Mitochondrial signal transduction." Cell Metabolism, 2022. 📄 PubMed |
Section 7: Economic Impact
| # | Citation |
|---|---|
| [81] | McKinsey Health Institute / World Economic Forum. "Youth Brain Health Crisis and Global Economy." 2025. 📄 WEF Article |
| [82] | McKinsey Health Institute. "Adding Years to Life and Life to Years." 2025. 📄 Report |
| [83] | Brookings Institution. "New Data Shows Long Covid Is Keeping as Many as 4 Million People Out of Work." 📄 Article |
| [84–85] | Business Collaborative for Brain Health. "Brain Capital: A Business Imperative." 2025. 📄 Report |
| [86] | McKinsey Health Institute, 2025. Lost productivity figures ($3.7T). 📄 Same source as [82] |
Section 8: International Comparisons
| # | Citation |
|---|---|
| [87] | Graham EL, et al. Northwestern Medicine / Frontiers in Human Neuroscience, 2026. Cross-country brain fog prevalence. 📄 Press release |
| [88] | "Long COVID symptoms in European adults 50+." BMC Infectious Diseases, 2025. 📄 PubMed Central |
| [89] | Hampshire A, et al. "Cognitive deficits in people who have recovered from COVID-19." NEJM, 2024. 📄 Full text |
| [90] | BMC Infectious Diseases, 2025. Pre-existing depression and post-COVID confusion. 📄 Same source as [88] |
| [91] | van der Feltz-Cornelis C, et al. "Prevalence of mental health conditions and brain fog in people with long COVID." General Hospital Psychiatry, 2024. 📄 Full text |
Section 9: Root Causes — Beyond COVID
| # | Citation |
|---|---|
| [92] | "Ultra-processed food consumption and health outcomes." BMJ, 2022. 📄 Full text |
| [93] | "Ultra-processed food and cognitive decline." JAMA Neurology, 2022. 📄 Abstract |
| [94] | Bankrate survey via CNBC, 2024. "90% of Americans Say Money Is a Source of Stress." 📄 Article |
| [95] | American Psychological Association. "Stress in America" survey, 2024. 📄 Report |
| [96] | Cigna. "The Loneliness Epidemic," 2024. 📄 Report |
| [97] | Livingston G, et al. "Dementia prevention, intervention, and care." The Lancet Commission, 2024. 📄 Full text |
| [98–99] | Centers for Disease Control and Prevention. Sleep and sleep disorders data, 2024. 📄 CDC data |
| [100] | Statista. "Average daily screen time in the United States," 2024. 📄 Data |
| [101] | Reviews.org. "Cell Phone Addiction," 2024. 📄 Report |
Section 10: Gender Differences
| # | Citation |
|---|---|
| [102] | Drapała J, et al. Frontiers in Human Neuroscience, 2024. Gender odds ratio for brain fog. 📄 Same source as [3] |
| [103] | Gava G, et al. "Cognition, Mood and Sleep in Menopausal Transition." Climacteric, 2022. 📄 PubMed |
| [104] | North American Menopause Society. Menopause and memory problems (60%). 📄 NAMS |
| [105] | Multiple studies on "pregnancy brain" prevalence (50–80%). |
Section 11: Children & Teens
| # | Citation |
|---|---|
| [106–107] | CLoCk Study. "Long COVID cognitive symptoms in children." Brain, Behavior, and Immunity, 2024. 📄 Full text |
| [108] | Common Sense Media. "The Common Sense Census: Media Use by Tweens and Teens." 📄 Report |
| [109] | ABCD Study / NIH. Screen time and cortical thickness. 📄 Springer |
| [110–111] | ABCD Study. Adolescent sleep disturbance prevalence, 2023. 📄 ScienceDirect |
Section 12: Long COVID & Cognitive Impact
| # | Citation |
|---|---|
| [112] | Kaiser Family Foundation. "Long COVID: What Do the Latest Data Show?" 2024. 📄 Brief |
| [113] | Graham EL, et al. Northwestern Medicine / Frontiers in Human Neuroscience, 2026. U.S. non-hospitalized patients, 86% brain fog. 📄 Press release |
| [114] | "What Is Brain Fog?" National Geographic, 2025. 📄 Article |
| [115–118] | Hampshire A, et al. "Cognitive deficits in people who have recovered from COVID-19." NEJM, 2024. IQ deficit data by COVID severity. 📄 Full text |
Section 13: The Lived Experience
| # | Citation |
|---|---|
| [119–125] | Reddit phenomenology study, 2023. Analysis of 717 first-person brain fog descriptions. Academic study of user-generated content. |
| [126] | YoungMinds study participant quote. |
| [127] | Reddit phenomenology study participant quote. |
Section 14: Evidence-Based Solutions
| # | Citation |
|---|---|
| [128] | Livingston G, et al. The Lancet Commission, 2024. Exercise and dementia risk (29% reduction). 📄 Same source as [97] |
| [129] | Erickson KI, et al. "Exercise training increases size of hippocampus." PNAS, 2011. 📄 PubMed |
| [130] | "Mediterranean diet and cognitive decline." Geroscience, 2025. 📄 Full text |
| [131] | Alzheimer's Association. MIND diet and cognitive decline risk. 📄 Alzheimer's Association |
| [132] | Yurko-Mauro K, et al. "Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline." Alzheimer's & Dementia, 2010. 📄 PubMed |
| [133] | Kennedy DO. "B Vitamins and the Brain." Nutrients, 2016; 8(2): 68. 📄 PubMed |
| [134] | Glade MJ, Smith K. "Phosphatidylserine and the human brain." Nutrition, 2015; 31(6): 781–786. 📄 PubMed |
| [135] | Boyle NB, et al. "The effects of magnesium supplementation on subjective anxiety and stress." Nutrients, 2017; 9(5): 429. 📄 PubMed |
| [136] | Avgerinos KI, et al. "Effects of creatine supplementation on cognitive function." Experimental Gerontology, 2018; 108: 166–173. 📄 PubMed |
| [137] | Yang G, et al. "Huperzine A for Alzheimer's disease: a systematic review." PLoS ONE, 2013; 8(9): e74916. 📄 PubMed |
| [138] | Mori K, et al. "Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment." Phytotherapy Research, 2009; 23(3): 367–372. 📄 PubMed |
Section 15: The Future of Brain Fog Research
| # | Citation |
|---|---|
| [139] | NIH RECOVER Initiative. Long COVID research funding ($1.15B). 📄 Website |
| [140] | Multiple sources on UK, EU, and private research funding for brain fog. |
| [141] | ClinicalTrials.gov. Bezisterim for neuroinflammation. 📄 ClinicalTrials.gov |
| [142] | ClinicalTrials.gov. Low-Dose Naltrexone for Long COVID. 📄 ClinicalTrials.gov |
| [143] | ClinicalTrials.gov. Hyperbaric Oxygen Therapy for Long COVID cognitive symptoms. 📄 ClinicalTrials.gov |
| [144] | ClinicalTrials.gov. Photobiomodulation for brain fog. 📄 ClinicalTrials.gov |
| [145] | ClinicalTrials.gov. Tocilizumab (anti-IL-6) for Long COVID. 📄 ClinicalTrials.gov |
Section 16: Measuring Brain Fog
| # | Citation |
|---|---|
| [146–150] | Debowska A, et al. "Brain Fog Scale (BFS): Scale Development and Validation." Personality and Individual Differences, 2024; 216: 112427. Scale properties, subscales, and reliability data. 📄 ScienceDirect |
A Note on Sources
Sources marked with 📄 link directly to the original study or official page. Historical sources (pre-digital publications from the 1800s–1960s) and aggregated statistics marked "Multiple sources" cannot be linked but are verifiable through academic databases like PubMed, Google Scholar, or institutional archives. If you need help locating a specific source, contact hi@sureokgo.com.
🎧 Want to deep dive? Listen to the podcast
Methodology & Sources
This database synthesizes 150 statistics from peer-reviewed research, government health agencies, and established research institutions. We prioritize primary sources and cite every statistic to its original publication.
Citation Index
This database contains 150 individually numbered citations from the following primary sources:
- Academic journals: Neurology, Nature Neuroscience, NEJM, JAMA Neurology, Lancet, BMJ, Frontiers in Human Neuroscience, Trends in Neurosciences, Geroscience, Climacteric, Brain Behavior and Immunity, General Hospital Psychiatry, BMC Infectious Diseases, Open Forum Infectious Diseases, Annals of Clinical and Translational Neurology
- Government agencies: CDC, NIH, WHO
- Research institutions: Yale School of Medicine, Trinity College Dublin, Northwestern Medicine
- Policy organizations: McKinsey Health Institute, Brookings Institution, Kaiser Family Foundation, World Economic Forum
- Historical sources: Ayonrinde (2020), Dunglison (1851), Mitchell (1877), Prince (1960), Beard (1869)
Medical Review
Content reviewed for medical accuracy by Dr. Alexandru-Theodor Amarfei, M.D. Senior consultant in geriatric medicine. Former chief of service. Post-covid recovery. Inventor of Fog off.
Updates & Corrections
This is a living database updated quarterly as new research emerges. Last updated: February 5, 2026. Next scheduled update: May 2026.
If you identify an error or have additional research to suggest, please contact: hi@sureokgo.com
How to Cite This Database
Brain Fog Statistics Database 2026. SureokGo. Retrieved February 5, 2026, from https://sureokgo.com/pages/brain-fog-statistics-2026
